Publications by authors named "Arthur Weinstein"

Claim this Profile
D
Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial.
Michael M Ward, Arthur Weinstein, Paloma Alejandro-Silva, Alan K Matsumoto, Rukmini Konatalapalli

Semin Arthritis Rheum· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naomi Rothfield, MD, MACR: A Giant Gift in a Small Package.
Arthur Weinstein

Rheum Dis Clin North Am· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus.
Roberta Vezza Alexander, Daniel Scott Rey, John Conklin, Vinicius Domingues, Mansoor Ahmed, Arthur Weinstein

Lupus Sci Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified Lupus.
Rosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, Cristina Arriens, Sonali Narain, Arthur Weinstein

ACR Open Rheumatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Complement Activation in SLE.
Arthur Weinstein, Roberta V Alexander, Debra J Zack

Curr Rheumatol Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et al.
Roberta Vezza Alexander, Arthur Weinstein

Arthritis Care Res (Hoboken)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Economic Benefit of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using a Multivariate Assay Panel (MAP).
Ann E Clarke, Arthur Weinstein, Andrew Piscitello, Avneet Heer, Tarun Chandra

ACR Open Rheumatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-Bound Complement Activation Products Are Superior to Serum Complement C3 and C4 Levels to Detect Complement Activation in Systemic Lupus Erythematosus: Comment on the Article by Aringer et al.
Arthur Weinstein

Arthritis Rheumatol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-bound complement activation products associate with lupus severity in SLE.
Cristina Arriens, Roberta Vezza Alexander, Sonali Narain, Amit Saxena, Christopher E Collins, Arthur Weinstein

Lupus Sci Med· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus.
Rosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, Daniel J Wallace, Sonali Narain, Arthur Weinstein

Arthritis Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE.
Daniel J Wallace, Roberta Vezza Alexander, Tyler O'Malley, Arezou Khosroshahi, Mehrnaz Hojjati, Arthur Weinstein

Lupus Sci Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.
Daniel J Wallace, Ellen M Ginzler, Joan T Merrill, Richard A Furie, William Stohl, Arthur Weinstein

Arthritis Rheumatol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reevaluating Serologic Markers of Poor Prognostic Factors in Rheumatoid Arthritis.
Arthur Weinstein, Brian McEVILLY, Thierry Dervieux

J Rheumatol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus.
Thierry Dervieux, John Conklin, Jo-Anne Ligayon, Leilani Wolover, Tyler O'Malley, Arthur Weinstein

J Immunol Methods· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and patient-reported outcomes of bilateral implantation of a +2.5 diopter multifocal intraocular lens.
Andrew Maxwell, Edward Holland, Lisa Cibik, Anna Fakadej, Gary Foster, Arthur Weinstein

J Cataract Refract Surg· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-bound complement activation products in systemic lupus erythematosus: comparison with anti-double-stranded DNA and standard complement measurements.
Chaim Putterman, Richard Furie, Rosalind Ramsey-Goldman, Anca Askanase, Jill Buyon, Arthur Weinstein

Lupus Sci Med· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
Ellen M Ginzler, Daniel J Wallace, Joan T Merrill, Richard A Furie, William Stohl, Arthur Weinstein

J Rheumatol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dr. Weinstein replies.
Arthur Weinstein

J Rheumatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
July consultation #4.
Arthur Weinstein

J Cataract Refract Surg· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
Kenneth C Kalunian, W Winn Chatham, Elena M Massarotti, Joyce Reyes-Thomas, Cole Harris, Arthur Weinstein

Arthritis Rheum· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of axial gout: a cross-sectional study.
Rukmini M Konatalapalli, Elena Lumezanu, James S Jelinek, Mark D Murphey, Hong Wang, Arthur Weinstein

J Rheumatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axial (spinal) gout.
Elena Lumezanu, Rukmini Konatalapalli, Arthur Weinstein

Curr Rheumatol Rep· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgG4-related disease.
Arthur Weinstein

N Engl J Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical experience with pseudophakic negative dysphotopsia.
Arthur Weinstein

J Cataract Refract Surg· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiscience and ethical concerns associated with advocacy of Lyme disease.
Paul G Auwaerter, Johan S Bakken, Raymond J Dattwyler, J Stephen Dumler, John J Halperin, Arthur Weinstein

Lancet Infect Dis· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis